Rankings
▼
Calendar
OMER Q4 2016 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$821M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
+93.3% YoY
Gross Profit
$13M
97.1% margin
Operating Income
-$12M
-91.9% margin
Net Income
-$20M
-152.1% margin
EPS (Diluted)
$-0.45
QoQ Revenue Growth
+14.3%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$67M
Total Liabilities
$105M
Stockholders' Equity
-$37M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$7M
+93.3%
Gross Profit
$13M
$6M
+100.1%
Operating Income
-$12M
-$18M
+34.3%
Net Income
-$20M
-$20M
+1.0%
← FY 2016
All Quarters
Q1 2017 →